All News about Obseva Sa![]() ![]() ![]()
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
November 22, 2022
From ObsEva SA
Via GlobeNewswire
![]() ![]() ![]() ![]()
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
October 26, 2022
From ObsEva SA
Via GlobeNewswire
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
September 01, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |